AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.8200
+0.0902 (12.36%)
At close: Jun 6, 2025, 4:00 PM
0.7828
-0.0372 (-4.54%)
After-hours: Jun 6, 2025, 7:03 PM EDT

AEON Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Market Capitalization
9222681,395214-
Upgrade
Market Cap Growth
-98.61%-91.93%-80.82%553.24%--
Upgrade
Enterprise Value
13382521,642428-
Upgrade
Last Close Price
0.7338.88518.40723.60699.12-
Upgrade
PE Ratio
0.010.51----
Upgrade
PB Ratio
--0.76-1.75-10.53-2.49-
Upgrade
Debt / Equity Ratio
-1.29-0.450.00-0.99-1.01-1.10
Upgrade
Asset Turnover
-----0.04
Upgrade
Quick Ratio
1.210.000.400.120.254.81
Upgrade
Current Ratio
1.430.110.480.120.254.86
Upgrade
Return on Equity (ROE)
------968.74%
Upgrade
Return on Assets (ROA)
-158.88%-348.25%-374.77%-351.67%-166.73%-15.11%
Upgrade
Return on Capital (ROIC)
----17752.57%-584.37%-18.81%
Upgrade
Earnings Yield
2025.60%194.61%-143.76%-3.77%-26.05%-
Upgrade
FCF Yield
-234.82%-94.01%-17.88%-2.57%-13.39%-
Upgrade
Buyback Yield / Dilution
97.00%99.25%-3896.62%-9.98%-1813.85%0.74%
Upgrade
Updated Mar 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q